“…Galangin (3,5,7-trihydroxyflavone) is regarded as the bioactive constituent of galangal, a perennial plant native of Indonesia but cultivated in many parts of Asia. The anticancer effects of galangin are mostly due to its abilities to inhibit cell cycle progression, inhibiting mitogen-activated protein kinase (MAPK) (Liu et al, 2015), protein kinase B (Akt) (Li et al, 2018), or mammalian target of rapamycin (mTOR) activity thereby inducing apoptotic cell death by activating caspase-9/-8/-3 and inhibiting tumor invasion and metastasis by reducing the upregulation of matrix metalloproteinase-2/-9 (Kong et al, 2019; Frontiers in Chemistry frontiersin.org Wu et al, 2024). These molecular pathways regulated by galangin are involved in suppressing different malignancies, such as lung cancer, hepatic cancer, ovarian cancer, breast cancer, gastric cancer, colorectal cancer, retinoblastoma, and osteosarcoma (Liang et al, 2021).…”